eylea

Generic: aflibercept

Labeler: regeneron pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name eylea
Generic Name aflibercept
Labeler regeneron pharmaceuticals, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVITREAL
Active Ingredients

aflibercept 40 mg/mL

Manufacturer
Regeneron Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 61755-005
Product ID 61755-005_130874ea-1e06-4ffc-b632-1dc8c73a9905
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125387
Listing Expiration 2026-12-31
Marketing Start 2011-11-21

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 61755005
Hyphenated Format 61755-005

Supplemental Identifiers

RxCUI
1232154 1232159 2693564 2693567
UNII
15C2VL427D
NUI
N0000193543 N0000193542

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eylea (source: ndc)
Generic Name aflibercept (source: ndc)
Application Number BLA125387 (source: ndc)
Routes
INTRAVITREAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/mL
source: ndc
Packaging
  • 1 SYRINGE, GLASS in 1 CARTON (61755-005-01) / .05 mL in 1 SYRINGE, GLASS
  • 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) / .05 mL in 1 VIAL, SINGLE-USE
  • 1 SYRINGE, GLASS in 1 CARTON (61755-005-54) / .05 mL in 1 SYRINGE, GLASS
  • 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-55) / .05 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (4)

Ingredients (1)

aflibercept (40 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVITREAL"], "spl_id": "130874ea-1e06-4ffc-b632-1dc8c73a9905", "openfda": {"nui": ["N0000193543", "N0000193542"], "unii": ["15C2VL427D"], "rxcui": ["1232154", "1232159", "2693564", "2693567"], "spl_set_id": ["f96cfd69-da34-41ee-90a9-610a4655cd1c"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (61755-005-01)  / .05 mL in 1 SYRINGE, GLASS", "package_ndc": "61755-005-01", "marketing_start_date": "20191209"}, {"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02)  / .05 mL in 1 VIAL, SINGLE-USE", "package_ndc": "61755-005-02", "marketing_start_date": "20111121"}, {"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (61755-005-54)  / .05 mL in 1 SYRINGE, GLASS", "package_ndc": "61755-005-54", "marketing_start_date": "20191209"}, {"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (61755-005-55)  / .05 mL in 1 VIAL, SINGLE-USE", "package_ndc": "61755-005-55", "marketing_start_date": "20140116"}], "brand_name": "EYLEA", "product_id": "61755-005_130874ea-1e06-4ffc-b632-1dc8c73a9905", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "61755-005", "generic_name": "aflibercept", "labeler_name": "Regeneron Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EYLEA", "active_ingredients": [{"name": "AFLIBERCEPT", "strength": "40 mg/mL"}], "application_number": "BLA125387", "marketing_category": "BLA", "marketing_start_date": "20111121", "listing_expiration_date": "20261231"}